Interactions on record — worth a quick check against your medications. Based on 2 of 24 ingredients. Check your meds →
Dietary supplement

Mycrobiome Probiotic Women's Formula Ingredients & Drug Interactions

by Solaray

Mycrobiome Probiotic Women's Formula label
See full label image
Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
Clinical methodology reviewed by · Updated Sep 23, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Mycrobiome Probiotic Women's Formula against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Moderate

Mycrobiome Probiotic Women's Formula is a dietary supplement by Solaray with 24 active ingredients. Its ingredients are commonly taken for digestive health and regularity, irritable bowel syndrome (ibs), diarrhea (including antibiotic-related).Based on those ingredients, 182 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are B. longum VPro55, L. acidophilus VPro80. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Mycrobiome Probiotic Women's Formula by Solaray

Ask about any prescription or over-the-counter medication and we check it for interactions with Mycrobiome Probiotic Women's Formula by Solaray — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.

HelloPharmacist Scorecard of Mycrobiome Probiotic Women's Formula by Solaray

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules · Last generated Jul 11, 2026

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 0 of its 24 active ingredients.
  • “Mycrobiome Women's Support Blend” is a proprietary blend — the label gives one combined amount (500 mg) without saying how much of each component you get.

This formula has 24 active probiotic ingredients — live microorganisms meant to support your gut health and digestion. Most of them are Lactobacillus and Bifidobacterium strains, with smaller amounts of other beneficial bacteria.

The inactive ingredients are common capsule fillers and binders: potato starch, cellulose, oat fiber, gum arabic, sunflower lecithin, sunflower oil, and silica.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Digestive health and balance with 24 strains.
  • We looked for evidence on: Antibiotic-associated diarrhea, Bacterial vaginosis, Clostridioides difficile infection, Constipation, Diarrhea, Inflammatory bowel disease (IBD) — and 4 related terms.
  • The strongest evidence on file: Lactobacillus Acidophilus is rated "Possibly Effective" for Antibiotic-associated diarrhea (Natural Medicines).
  • Also on file: Lactobacillus Acidophilus is rated "Possibly Effective" for Bacterial vaginosis, Irritable bowel syndrome (IBS).
  • Also on file: Lactobacillus Acidophilus is rated "Insufficient Reliable Evidence To Rate" for Constipation, Inflammatory bowel disease (IBD), Radiation-induced diarrhea, Lactose intolerance.

The evidence we hold is limited to one ingredient — L. acidophilus — and it's promising for a few uses. L. acidophilus is possibly effective for irritable bowel syndrome (IBS), antibiotic-associated diarrhea, Helicobacter pylori infection, and bacterial vaginosis.

For the other 23 strains in this product, we don't have effectiveness data on file, so we can't tell you what science says about them specifically. Talk to your pharmacist about whether this formula fits your health goal.

The evidence, ingredient by ingredient Bifidobacterium Longum Lactobacillus Acidophilus

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

L. acidophilus and B. longum are both generally well tolerated in healthy adults, though both carry rare risks in seriously ill or immune-compromised people. The most common side effects when taken orally are mild gastrointestinal ones — flatulence, bloating, abdominal discomfort, and diarrhea — though these are uncommon.

Very rarely, these probiotics have caused serious infections like bacteremia or sepsis, but those cases happened almost entirely in critically ill patients or infants. For pregnancy and breastfeeding, B. longum is rated possibly safe; we don't have safety data on file for L. acidophilus during these times.

Check with your doctor before using this product if you're breastfeeding or pregnant.

Side effects, ingredient by ingredient Bifidobacterium Longum Lactobacillus Acidophilus

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 2 of the 2 matched ingredients can interact with medications — Lactobacillus Acidophilus, Bifidobacterium Longum.
  • The most serious interaction on file is rated Moderate.
  • For scale: 182 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Antibiotic drugs are the only medication type we documented interacting with the two probiotics we could check. If you take antibiotics, separate them from this supplement by a few hours so the drugs don't kill off the live organisms in the formula.

For the other 22 strains, we have no interaction data, so check your exact medications in the tool on this page.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

This is a multi-strain probiotic aimed at women's digestive and vaginal health. If you're generally healthy and take no antibiotics, it's likely a reasonable choice — but space it away from any antibiotics by a few hours.

If you're seriously ill, immune-compromised, pregnant, or breastfeeding, talk with your doctor first. Run your medications through our checker before you start.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 24 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Sep 25, 2025.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Mycrobiome Probiotic Women's Formula, straight from the product label.

Brand Solaray
Barcode (UPC) 076280737202
Net contents 30 VegCap(s)
Market status On market
Date entered into DSLD Sep 25, 2025
DSLD ID 338495
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Vegan, Vegetarian, Adult Female (18 - 50 Years), Seniors/Mature (>50 Years) - Women ONLY, Gluten Free, Dairy Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Mycrobiome Probiotic Women's Formula by Solaray, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Enteric VegCap(s)
Maximum serving Sizes:
1 Enteric VegCap(s)
Servings per container
30
UPC/BARCODE
076280737202
IngredientAmount% DV
B. animalis lactis VK20 NP--
B. longum infantis VPro530 NP--
B. breve VPro520 NP--
B. bifidum VPro510 NP--
L. rhamnosus VPro110 NP--
L. brevis VPro180 NP--
L. delbrueckii VPro3150 NP--
L. plantarum VPro100 NP--
L. bulgaricus VPro120 NP--
Lc. lactis VPro420 NP--
E. faecium VPro210 NP--
Lc. cremoris VPro410 NP--
L. salivarius VPro150 NP--
Mycrobiome Women's Support Blend500 mg--
L. fermentum VPro140 NP--
L. helveticus VPro130 NP--
P. acidilacti VPro290 NP--
S. thermophilus VPro230 NP--
L. gasseri VPro160 NP--
L. kefir VPro190 NP--
L. paracasei Vpro 2240 NP--
L. casei VK40 NP--
L. lactis VPro340 NP--
B. longum VPro550 NP--
L. acidophilus VPro800 NP--

Other ingredients: Potato Starch, Cellulose, Oat Fiber, Gum Arabic, Sunflower Lecithin, Sunflower Oil, Silica

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Brand IP Statement(s)

Solaray Est 1973

Formula

+ 24 Strains + Prebiotic 50 Billion live cultures Enteric shield

FDA Statement of Identity

Dietary Supplement

Seals/Symbols

Lab Verified Vegan

Formulation

Gluten Free

Vegan

Made without soy

Precautions

Warning: Do not use if safety seal is broken or missing.

Keep out of reach of children.

Keep you licensed health care practitioner informed when using this product.

Do not take within two hours of taking antibiotics.

Suggested/Recommended/Usage/Directions

Directions: Use only as directed. Take 1 Enteric vegcap daily with a glass of water.

Storage

Keep refrigerated.

FDA Disclaimer Statement

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements

100% PCR Bottles

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Mycrobiome Probiotic Women's Formula by Solaray label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Mycrobiome Probiotic Women's Formula label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Mycrobiome Probiotic Women's Formula by Solaray

These are the 24 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Enteric VegCap(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Mycrobiome Women's Support Blend

500 mg per serving
  • › B. animalis lactis VK2
  • › B. longum infantis VPro53
  • › B. breve VPro52
  • › B. bifidum VPro51
  • › L. rhamnosus VPro11
  • › L. brevis VPro18
  • › L. delbrueckii VPro315
  • › L. plantarum VPro10
  • › L. bulgaricus VPro12
  • › Lc. lactis VPro42
  • › E. faecium VPro21
  • › Lc. cremoris VPro41
  • › L. salivarius VPro15
  • › L. fermentum VPro14
  • › L. helveticus VPro13
  • › P. acidilacti VPro29
  • › S. thermophilus VPro23
  • › L. gasseri VPro16
  • › L. kefir VPro19
  • › L. paracasei Vpro 224
  • › L. casei VK4
  • › L. lactis VPro34
  • › B. longum VPro55
  • › L. acidophilus VPro80

Other (inactive) ingredients: Potato Starch, Cellulose, Oat Fiber, Gum Arabic, Sunflower Lecithin, Sunflower Oil, Silica. These complete the product’s ingredient list but are not active constituents.

Interaction report

Mycrobiome Probiotic Women's Formula by Solaray Drug Interactions

Want to check YOUR meds against Mycrobiome Probiotic Women's Formula?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
182Drugs
182 Moderate

Ingredients driving the most interactions

B. longum VPro55 182
L. acidophilus VPro80 182

Individual Drug Interactions

The ingredients in Mycrobiome Probiotic Women's Formula interact with 182 drugs. Click any drug to see the details.

2 of the 24 ingredients in Mycrobiome Probiotic Women's Formula interact with drugs. Each result below shows which ingredient is responsible. B. longum VPro55 L. acidophilus VPro80

Each ingredient & the kinds of drugs it affects

For each ingredient in Mycrobiome Probiotic Women's Formula with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

B. longum VPro551 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Bifidobacterium longum with antibiotic drugs might decrease the effectiveness of B. longum.
Since B. longum preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. longum preparations by at least 2 hours.

Likelihood Probable Evidence D
B. longum VPro55 full monograph & interactions

L. acidophilus VPro801 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Lactobacillus acidophilus with antibiotic drugs might decrease the effectiveness of L. acidophilus.
L. acidophilus preparations usually contain live and active organisms. Therefore, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and L. acidophilus preparations by at least two hours.

Likelihood Probable Evidence D
L. acidophilus VPro80 full monograph & interactions
The maker

Brand information

Manufacturer and brand details for Mycrobiome Probiotic Women's Formula, from the product label.

Solaray

See all Solaray products
Name
Solaray
City
Salt Lake City
State
UT
ZipCode
84101
Phone Number
800-538-5888
Web Address
www.solaray.com
Pharmacist Counseling Corner

Mycrobiome Probiotic Women's Formula by Solaray: Common Questions

Does Mycrobiome Probiotic Women's Formula by Solaray interact with any medications?
Yes. Based on its ingredients, Mycrobiome Probiotic Women's Formula has a known interaction with 182 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Mycrobiome Probiotic Women's Formula contains 24 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I take this while I'm on an antibiotic?
Yes, but timing matters. The antibiotic can kill the live probiotics in this formula, making it less effective. Space them a few hours apart — take your antibiotic at one time and the probiotic at another. Your pharmacist can help you pick the exact schedule.
What does L. acidophilus actually do?
It's a Lactobacillus strain that's possibly effective for irritable bowel syndrome, antibiotic-associated diarrhea, Helicobacter pylori infection, and bacterial vaginosis. It's one of two probiotics in this formula we have effectiveness data for.
Are there side effects?
Most people tolerate it fine. Mild gas, bloating, and abdominal discomfort can happen, especially early on, but they're uncommon. Very rarely, serious infections have occurred, but almost only in critically ill patients. If you're healthy, the risk is low.
Is it safe to use while breastfeeding?
B. longum is rated possibly safe during breastfeeding. We don't have safety data on file for L. acidophilus or the other 22 strains during breastfeeding, so talk with your doctor or pharmacist for personalized advice before you start.
What are all these bacterial strains for?
This is a multi-strain blend designed to support women's gut and vaginal health. Most are Lactobacillus and Bifidobacterium species — common beneficial bacteria. The formula has 24 strains total, though we only have effectiveness data for one of them.
Why don't you have data on most of the ingredients?
We hold monographs — detailed interaction and safety files — on only the most commonly studied probiotics. These 22 strains may be studied in other sources or marketed on their own track record, but we haven't built interaction data for them yet.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Mycrobiome Probiotic Women's Formula is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Mycrobiome Probiotic Women's Formula label
Go deeper

The Full Monographs Behind Mycrobiome Probiotic Women's Formula’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Herb & supplement monograph

Bifidobacterium Longum

Interacts with 182 drugs

Bifidobacterium longum is a 'friendly' bacterium found naturally in the human gut and used as a probiotic. It is generally well tolerated and is most studied for digestive issues, though evi...

Read the full Bifidobacterium Longum monograph → Herb & supplement monograph

Lactobacillus Acidophilus

Interacts with 182 drugs

Lactobacillus acidophilus is a 'friendly' bacterium used as a probiotic to support gut and vaginal health. It is generally well tolerated in healthy people, and there is reasonable evidence...

Read the full Lactobacillus Acidophilus monograph →
Sources

Sources & How We Checked

Mycrobiome Probiotic Women's Formula's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 36 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Bifidobacterium Longum 21 references
  1. Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol 1999;37:1227-8.
  2. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  3. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  4. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130(6):1355-60. PubMed
  5. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  6. Pellonperä O, Vahlberg T, Mokkala K, et al. Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil. Br J Nutr. 2020 Nov 4:1-11. PubMed
  7. Pellonperä O, Mokkala K, Houttu N, et al. Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: A randomized, placebo-controlled, double-blind clinical trial PubMed
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
  10. Enomoto T, Sowa M, Nishimori K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int 2014;63(4):575-85. PubMed
  11. US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
  12. Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. PubMed
  13. Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022;28(7):732-744.
  14. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52(11) PubMed
  15. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
  16. Tamaki H, Nakase H, Inoue S, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc 2016;28(1):67-74.
  17. Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7. PubMed
  18. Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6.
  19. Tena D, Losa C, Medina MJ, Sáez-Nieto JA. Peritonitis caused by Bifidobacterium longum: case report and literature review. Anaerobe 2014;27:27-30. PubMed
  20. Sangkanjanavanich S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, Boonpiyathad T. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Ann Allergy Asthma Immunol 2022;129(6):790-792. PubMed
  21. Wilson HL, Ong CW. Bifidobacterium longum vertebrodiscitis in a patient with cirrhosis and prostate cancer. Anaerobe 2017;47:47-50. PubMed

See these in context on the Bifidobacterium Longum monograph →

Lactobacillus Acidophilus 15 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48(10):1127-35 PubMed
  3. Chatterjee S, Kar P, Das T, Ray S, Gangulyt S, Rajendiran C, Mitra M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated
  4. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M,Minakari M, Shavakhi S, Gholamrezaei A. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-c
  5. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 2016;42(4):234-41. PubMed
  6. Badehnoosh B, Karamali M, Zarrati M, et al. The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med. 2018 May;31(9):1128-1136.
  7. Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabete
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Xiao SD, Zhang DZ, Lu H, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60.
  10. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  11. Ozer M, Goksu SY, Shahverdiani A, Mustafa M. Lactobacillus acidophilus-induced endocarditis and associated splenic abscess. Case Rep Infect Dis 2020;2020:1382709.
  12. Sadrin S, Sennoune S, Gout B, et al. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52(5):534-540. PubMed
  13. Stoffer JN, Slingsby TJ, Giuliari GP. Lactobacillus acidophilus endophthalmitis after intravitreal bevacizumab injection requiring intraocular lens explantation. Can J Ophthalmol 2022;57(1):e21-e22. PubMed
  14. Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 2006;73(2-3):107-10.
  15. Hui J, Ren Y, Wang Y, Han Q. Lactobacillus acidophilus endophthalmitis postcataract operation: A case report with a literature review. Ocul Immunol Inflamm 2023.

See these in context on the Lactobacillus Acidophilus monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team